Cost-Effectiveness Analysis Of Venetoclax For Treatment Of Refractory/Relapsed Chronic Lymphocytic Leukemia With Or Without 17P Deletion In Bulgaria
| Autor: | Dima K. Tsanova, S Djambazov, N Veleva, T Vekov |
|---|---|
| Rok vydání: | 2017 |
| Předmět: |
0301 basic medicine
Oncology medicine.medical_specialty 17p deletion Venetoclax business.industry Health Policy Public Health Environmental and Occupational Health Cost-effectiveness analysis Relapsed chronic lymphocytic leukemia 03 medical and health sciences chemistry.chemical_compound 030104 developmental biology 0302 clinical medicine Refractory chemistry 030220 oncology & carcinogenesis Internal medicine medicine business |
| Zdroj: | Value in Health. 20:A754 |
| ISSN: | 1098-3015 |
| DOI: | 10.1016/j.jval.2017.08.2119 |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect